Domo & Regional One: 2023 Roi Winners

By Author: Arina Smith
Total Articles: 185
Comment this article

Domo (Nasdaq: DOMO) and Regional One Health have been honored with the 2023 Nucleus Research ROI Award for achieving an outstanding total ROI of 190%. This remarkable accomplishment was attributed to the adoption of Domo's data experience platform, which facilitated significant improvements in patient care, operational efficiencies, and revenue generation for Regional One Health, a prominent healthcare organization.

Regional One Health is dedicated to revolutionizing healthcare delivery through data-driven decision-making. In partnership with Domo, they collaborated closely with healthcare professionals to identify critical data points essential for informed care decisions, including metrics like patient satisfaction and length of stay. Leveraging the Domo platform, they tracked progress towards these vital goals.

Dr. Kito Lord, Senior Medical Director and Physician Advisor at Regional One Health, emphasized the importance of data in their operations, stating, "Domo takes complex information and helps simplify it, giving us the evidence we need through real-time data to drive innovation, make better decisions, ...
... and improve patient outcomes."

By utilizing Domo's capabilities, Regional One Health streamlined care practices through data visualizations, resulting in reduced patient length of stay and improved access to prescriptions, ultimately enhancing patient safety.

Furthermore, Regional One Health implemented pharmacy billing and collections databases through Domo, which included a range of decision support applications and dashboards tailored to optimize hospital pharmacy operations. These enhancements not only reduced expenses by $100,000 annually but also doubled the hospital's revenue capture rate.

Mark Maughan, SVP of customer success at Domo, praised Regional One Health's dedication to data-driven innovations, noting, "The data experience innovations they have created deliver monumental gains for the organization and most importantly, help to change lives."

In summary, Domo and Regional One Health's collaboration has earned them the 2023 Nucleus Research ROI Award for achieving a remarkable 190% total ROI. Their commitment to data-driven decision-making and innovative use of the Domo platform has led to substantial improvements in patient care, operational efficiency, and revenue generation for Regional One Health.

About Nucleus Research:

Nucleus Research is a globally recognized leader in ROI technology research, offering research streams and advisory services that enable both vendors and end users to quantify and maximize the returns on their technology investments.

About Domo:

Domo is committed to empowering organizations to harness the power of data to drive business impact. Their cloud-native data experience platform goes beyond traditional business intelligence and analytics, making data visible and actionable through user-friendly dashboards and applications. Domo's platform, underpinned by AI and data science, provides a secure foundation for connecting with existing cloud and legacy systems, enabling companies to optimize critical business processes at scale and accelerate results.

For more information, please visit www.domo.com or follow Domo on social media platforms such as Twitter, Facebook, and LinkedIn.

Domo is a registered trademark of Domo, Inc.